Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Cytidine and Omega-3 Fatty Acids in Bipolar Disorder

This study has been completed.
Sponsor:
Collaborator:
Stanley Medical Research Institute
Information provided by (Responsible Party):
Beth L. Murphy MD, PhD, Mclean Hospital
ClinicalTrials.gov Identifier:
NCT00854737
First received: February 27, 2009
Last updated: April 19, 2012
Last verified: April 2012
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: July 2010
  Primary Completion Date: August 2007 (Final data collection date for primary outcome measure)
No publications provided by Mclean Hospital

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):